Polysomnography findings and risk factors for sleep-disordered breathing in patients with systemic sclerosis

Ebru Çakır Edis, Renginar Mutlucan Eraslan, Osman Hatipoğlu

DOI: 10.46497/ArchRheumatol.2021.8415

Issue: Volume 36 - Issue 3 - September 2021
1662 1569

Identification of sequence polymorphisms in the mitochondrial deoxyribonucleic acid displacement-loop region as risk factors for systemic lupus erythematosus

Ruixue Lai, Xiaoyun Zhang, Kuangyuan Qiao, Xueqing Gao, Shang Li, Ruixing Zhang, Yixin Qi, Chenxing Peng

DOI: 10.46497/ArchRheumatol.2021.8101

Issue: Volume 36 - Issue 3 - September 2021
1893 1898

A preliminary study of possible fibrotic role of meprin metalloproteases in scleroderma patients

Ayşe Koçak, Aydan Köken Avşar, Duygu Harmancı, Gül Akdoğan, A. Merih Birlik

DOI: 10.46497/ArchRheumatol.2021.8581

Issue: Volume 36 - Issue 4 - December 2021
1507 2029

Screening and identification of potential biomarkers and therapeutic targets for systemic sclerosis-associated interstitial lung disease

Biqing Huang, Jing Li, Jiuliang Zhao

DOI: 10.46497/ArchRheumatol.2021.8625

Issue: Volume 36 - Issue 4 - December 2021
1992 2414

Serum lysyl oxidase concentration increases in long-standing systemic sclerosis: Can lysyl oxidase change over time?

Mohammad Hassan Jokar, Simin Jafaripour, Nafiseh Abdollahi, Maryam Nazemipour, Maliheh Moradzadeh, Mohammad Ali Mansournia

DOI: 10.46497/ArchRheumatol.2022.8977

Issue: Volume 37 - Issue 2 - June 2022
1328 1813

Association of TNFAIP3 gene polymorphism (rs5029939) with susceptibility and clinical phenotype of systemic lupus erythematosus

Hala Gaballah, Reham Abd-elkhalek, Ola Hussein, Shimaa Abd El-wahab

DOI: 10.46497/ArchRheumatol.2022.8769

Issue: Volume 36 - Issue 4 - December 2021
1296 1654

Persistent eosinophilia and associated organ involvement in Thai patients with systemic sclerosis: Data from the Siriraj scleroderma cohort

Somsak Punjasamanvong, Chayawee Muangchan

DOI: 10.46497/ArchRheumatol.2021.8855

Issue: Volume 36 - Issue 4 - December 2021
1697 1417

Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan

Sadia Asif, Asadullah Khan, Muhammad Faiq, Zia Ud Din, Sarmad Zahoor, Muhammad Haroon

DOI: 10.46497/ArchRheumatol.2021.8701

Issue: Volume 36 - Issue 4 - December 2021
1315 1643

Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study

Emine Müge Acar, Senem Şaş, Fatmanur Aybala Koçak

DOI: 10.46497/ArchRheumatol.2022.8645

Issue: Volume 37 - Issue 2 - June 2022
8918 2027

Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study

Sherif M Gamal, Nermeen Fouad, Nora Yosry, Wael Badr, Nesreen Sobhy

DOI: 10.46497/ArchRheumatol.2022.8888

Issue: Volume 37 - Issue 2 - June 2022
1757 1973

Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus

Jiayi LIN, Yaqin ZHANG, Meihua WANG, Yang ZHANG, Pin LI, Yingping CAO, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2022.8252

Issue: Volume 37 - Issue 2 - June 2022
1735 2433

Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic

Yasmin Adel, Mohamed Elgamal, Sherehan Adel Abdelsalam

DOI: 10.46497/ArchRheumatol.2022.8996

Issue: Volume 37 - Issue 2 - June 2022
1836 1962

Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China

Ke Zhang, Chunmei He, Qiaoting Deng, Wengen Li, Zhixiong Zhong, Jingyuan Hou

DOI: 10.46497/ArchRheumatol.2022.8870

Issue: Volume 37 - Issue 1 - March 2022
1139 1807

Evaluation of personality disorders using the structured clinical interview for DSM-5 personality disorders, quality of life, and disease activity in patients with systemic lupus erythematosus

Yunus Durmaz, İlker İlhanlı, Pınar Durmaz

DOI: 10.46497/ArchRheumatol.2022.9002

Issue: Volume 37 - Issue 3 - September 2022
1465 1560

Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study

Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee

DOI: 10.46497/ArchRheumatol.2022.9140

Issue: Volume 37 - Issue 3 - September 2022
1339 1063

Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients

Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi

DOI: 10.46497/ArchRheumatol.2022.9217

Issue: Volume 37 - Issue 3 - September 2022
1367 1153

Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience

Ferhat Demir, Eda Gürler, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2022.8998

Issue: Volume 37 - Issue 3 - September 2022
1529 1212

The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus

Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec

DOI: 10.46497/ArchRheumatol.2022.9255

Issue: Volume 37 - Issue 4 - December 2022
1229 1333

MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis

Xinglan Huang, Peng Yan, Xinghua Song, Suiying Zhang, Yuqiong Deng, Caifeng Huang, Xiaoqing Zhao, Sheng Liu, Xiping Cheng, Dongjiang Liao

DOI: 10.46497/ArchRheumatol.2022.9168

Issue: Volume 37 - Issue 4 - December 2022
1568 1581

The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients

Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed

DOI: 10.46497/ArchRheumatol.2022.9307

Issue: Volume 37 - Issue 4 - December 2022
1272 1085